Through
Histogen's patented technology process, fibroblast cells are induced to become multipotent stem cells, and there is upregulation of growth factors which have been shown to be important in hair viability.
"We are excited to partner with
Histogen Aesthetics."
Histogen Aesthetics will continue sales of the 11 existing CellCeuticals Biomedical Skin Treatments skin care products, while bringing new innovation to the line through the addition of what it calls "a unique regenerative medicine technology, working to improve skin aging at a cellular level."
SAN DIEGO, Calif., July 25, 2017 --
Histogen, Inc., announced that its proprietary multipotent cell conditioned media will be marketed by biopharmaceutical company Allergan within the recently-acquired Regenica Advanced Rejuvenation System.
Led by former Broadcom chairman John Major and
Histogen founder and CEO Gail Naughton, judges included representatives of UCSD's Rady School of Management, CSU San Marcos' School of Business and the La Jolla Institute, as well as several entrepreneurs who have successfully navigated the M&A process.
Naughton serves as the chief executive officer and the chair of the board of
Histogen as well as a member of the board of directors for CR Bard.
Gail Naughton - Founder, chairman and CEO of
Histogen Inc., a regenerative medicine company.
San Diego, Calif.-based
Histogen Inc., a regenerative medicine company, and Suneva Medical, a privately-held aesthetics company, said they have entered into a license agreement for physician-dispensed aesthetic products containing
Histogen's proprietary multipotent cell conditioned media (CCM).
8 October 2013 a[euro]" US Stratus Media Group Inc (OTCBB:SMDI) said it had inked a letter of intent (LoI) to buy regenerative medicine company
Histogen Inc for an undisclosed sum.
8 October 2013 - US Stratus Media Group Inc (OTCBB:SMDI) said it had inked a letter of intent (LoI) to buy regenerative medicine company
Histogen Inc for an undisclosed sum.